Opaleye Management Inc. Q2 2018 Filing
Filed August 14, 2018
Portfolio Value
$386.4M
Holdings
36
Report Date
Q2 2018
Filing Type
13F-HR
All Holdings (36 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | AXGNAXOGEN INC | 1,440,000 | $72.4M | 18.73% | |
| 2 | —LOXO ONCOLOGY | 175,000 | $30.4M | 7.86% | |
| 3 | CDXSCODEXIS INC | 1,750,000 | $25.2M | 6.52% | |
| 4 | FGENEURFIBROGEN INC | 360,000 | $22.5M | 5.83% | |
| 5 | 2L9BLUEPRINT MEDICINES | 350,000 | $22.2M | 5.75% | |
| 6 | —POLARITYTE INC | 800,000 | $18.8M | 4.87% | |
| 7 | DCPHEURDECIPHERA PHARMACEUTICALS IN | 420,000 | $16.5M | 4.28% | |
| 8 | VKTXVIKING THERAPEUTICS INC | 1,200,000 | $11.4M | 2.95% | |
| 9 | —STRONGBRIDGE BIOPHARMA PLC | 1,830,000 | $11.0M | 2.84% | |
| 10 | AGIOAGIOS PHARMACEUTICALS | 130,000 | $10.9M | 2.83% | |
| 11 | FRXFENNEC PHARMACEUTICALS INC | 945,000 | $9.9M | 2.55% | |
| 12 | CBAYUSDCYMABAY THERAPEUTICS INC | 697,500 | $9.4M | 2.42% | |
| 13 | TGTXTG THERAPEUTICS INC | 625,000 | $8.2M | 2.13% | |
| 14 | AMAGAMAG PHARMACEUTICALS INC | 420,000 | $8.2M | 2.12% | |
| 15 | —MIRAGEN THERAPEUTICS INC | 1,200,000 | $7.7M | 1.99% | |
| 16 | OCULOCULAR THERAPEUTIX INC | 1,111,000 | $7.5M | 1.94% | |
| 17 | —MAGENTA THERAPEUTICS INC | 550,000 | $7.4M | 1.92% | |
| 18 | —AUDENTES THERAPEUTICS INC | 190,000 | $7.3M | 1.88% | |
| 19 | GBYSANGAMO BIOSCIENCES INC | 505,000 | $7.2M | 1.86% | |
| 20 | XOMAXOMA CORP DEL | 320,200 | $6.7M | 1.73% | |
| 21 | XNCRXENCOR INC | 180,000 | $6.7M | 1.72% | |
| 22 | —CORIUM INTERNATIONAL INC | 800,000 | $6.4M | 1.66% | |
| 23 | —CIDARA THERAPEUTICS INC | 1,200,000 | $6.2M | 1.62% | |
| 24 | RAREULTRAGENYX PHARMACEUTICALS INC | 80,000 | $6.1M | 1.59% | |
| 25 | PTCTPTC THERAPEUTICS INC | 180,000 | $6.1M | 1.57% | |
| 26 | APLSAPELLIS PHARMACEUTICALS INC | 265,000 | $5.8M | 1.51% | |
| 27 | CMRXEURCHIMERIX INC | 1,150,000 | $5.5M | 1.42% | |
| 28 | AMRNAMARIN CORP PLC | 1,750,000 | $5.4M | 1.40% | |
| 29 | —BIOFRONTERA AG | 391,400 | $4.8M | 1.23% | |
| 30 | —GTX INC | 250,000 | $3.8M | 0.99% | |
| 31 | —EPIZYME INC | 275,000 | $3.7M | 0.96% | |
| 32 | —ARQULE INC | 420,000 | $2.3M | 0.60% | |
| 33 | —PROTALIX BIOTHERAPEUTICS INC | 3,100,000 | $1.3M | 0.35% | |
| 34 | CTIC1USDCTI BIOPHARMA CORP | 161,400 | $803K | 0.21% | |
| 35 | —AZURRX BIOPHARMA INC | 130,000 | $417K | 0.11% | |
| 36 | —BIOLINERX LTD | 250,000 | $222K | 0.06% |